Pfizer Inc. (NYSE: PFE) said Tuesday that its third-quarter revenue surges on the acquisition of fellow drugmaker Wyeth, but charges ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE